MODERN APPROACHES TO THE TREATMENT OF PROLACTINOMAS IN WOMEN

Article Sidebar

Published Feb 25, 2021
Download
pdf
Statistic
Vol. 7 No. 02 (2021): journalnx.

Main Article Content

Z. Y. XALIMOVA
D. M. S. Department of Endocrinology and Pediatric Endocrinology, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
D. U. URALOVA
Master Student, Department of Endocrinology and Pediatric Endocrinology, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
M. S. SAFAROVA
Y. O. JURAYEVA
A A GUMAROVA

Abstract

Hyperprolactinemia syndrome is one of the most common neuroendocrine disorders. In 60% of cases, hyperprolactinemia outside lactation is caused by lactotrophic adenomas of the pituitary gland (prolactinomas), which account for about 40% of all pituitary adenomas. The incidence of prolactinomas, on average, ranges from 6 to 10 new cases per 1 million adult population per year. The article is dedicated to topical issues of the treatment of prolactinomas.

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Z. Y. XALIMOVA, D. U. URALOVA, M. S. SAFAROVA, Y. O. JURAYEVA, & A A GUMAROVA. (2021). MODERN APPROACHES TO THE TREATMENT OF PROLACTINOMAS IN WOMEN. JournalNX - A Multidisciplinary Peer Reviewed Journal, 7(02), 321–326. Retrieved from https://repo.journalnx.com/index.php/nx/article/view/2422